Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Rome Tor Vergata
About this trial
BMI is a simple and widely recorded variable that may capture obesity or cachexia in cancer patients. How BMI is associated to health-related quality of life (HR-QoL) in such patients is poorly investigated.
High BMI may be associated to obesity, an increased burden of comorbidity, reduced physical activity and, in some settings, to more aggressive oncological disease. On the other hand, low BMI may reflect enhanced weight loss, cachectic syndrome, higher tumor burden and adverse prognostic features which all deteriorate quality of life. The aim of the present study is to evaluate the association of BMI and HR-QoL as measured by the EORTC-QLQ-C30 questionnaire in several cancer settings (such as localized vs metastatic or distinct primary tumors).
Eligibility criteria
Qualifiers
Histologically confirmed diagnosis of solid tumor
Age >18 years
Signed informed consent
Life expectancy > 12 weeks
Disqualifiers
Inability to fill out the EORTC QLQ-C30 questionnaire.
Absence of a certain diagnosis of solid tumor (e.g. subjects on screening programs)
Diagnosis of second malignancies that might bias results interpretation
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,380 Participants
are grouped into 1 trial groupSponsors and collaborators
University of Rome Tor Vergata
Lead sponsor
S.I.C.O.G. partners
Collaborator
Source ClinicalTrials.gov